Home/ Stocks/ FBRX

Forte Biosciences, Inc. Common Stock

FBRX XNAS

$25.72 +0.14 (+0.55%) ▲ 15-min delayed

Open

$25.07

High

$26.40

Low

$24.43

Volume

154.4K

Market Cap

$320.81M

About Forte Biosciences, Inc. Common Stock

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 16 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-17,682,000	$-0.99
Q2 2025	$0	$-11,249,000	$-0.96
Q1 2025	$0	$-15,656,000	$-1.37
FY 2024	$1.31M	$-35,478,000	$-12.17

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

Related Market News

No specific coverage for FBRX yet. Check out our latest market news or earnings calendar.

Get FBRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Forte Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.